Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment.

Schurigt U, Eilenstein R, Gajda M, Leipner C, Sevenich L, Reinheckel T, Peters C, Wiederanders B, Bräuer R.

Inflamm Res. 2012 Sep;61(9):1021-9. doi: 10.1007/s00011-012-0495-x. Epub 2012 Jun 7.

PMID:
22674323
2.

Comparison of different methods for preparation and characterization of total RNA from cartilage samples to uncover osteoarthritis in vivo.

Ruettger A, Neumann S, Wiederanders B, Huber R.

BMC Res Notes. 2010 Jan 18;3:7. doi: 10.1186/1756-0500-3-7.

3.

Selectivity of propeptide-enzyme interaction in cathepsin L-like cysteine proteases.

Schilling K, Körner A, Sehmisch S, Kreusch A, Kleint R, Benedix Y, Schlabrakowski A, Wiederanders B.

Biol Chem. 2009 Feb;390(2):167-74. doi: 10.1515/BC.2009.023.

PMID:
19040358
4.

Microplate assay for cathepsin detection in viable cells using derivatives of 4-methoxy-beta-naphthylamide.

Ruettger A, Wiederanders B.

Curr Protoc Protein Sci. 2007 Aug;Chapter 21:Unit 21.21. doi: 10.1002/0471140864.ps2121s49.

PMID:
18429321
5.

Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.

Schurigt U, Hummel KM, Petrow PK, Gajda M, Stöckigt R, Middel P, Zwerina J, Janik T, Bernhardt R, Schüler S, Scharnweber D, Beckmann F, Saftig P, Kollias G, Schett G, Wiederanders B, Bräuer R.

Arthritis Rheum. 2008 Feb;58(2):422-34. doi: 10.1002/art.23224.

6.
7.

[Intra-articular pain during gonarthrosis: a case report about an extremely increased cathepsin expression in chondrocytes].

Müller C, Wiederanders B, Fuhrmann R, Venbrocks RA, Mollenhauer J, Claussen U, Rüttger A.

Z Orthop Unfall. 2007 May-Jun;145(3):313-6. German.

PMID:
17607629
8.

Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction.

Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schütz A, Kovacic B, Friedrich K.

Neoplasia. 2007 Apr;9(4):279-91.

9.

Optimized folding and activation of recombinant procathepsin L and S produced in Escherichia coli.

Kramer G, Paul A, Kreusch A, Schüler S, Wiederanders B, Schilling K.

Protein Expr Purif. 2007 Jul;54(1):147-56. Epub 2007 Feb 21.

PMID:
17391985
10.

Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.

Rückrich T, Brandenburg J, Cansier A, Müller M, Stevanović S, Schilling K, Wiederanders B, Beck A, Melms A, Reich M, Driessen C, Kalbacher H.

Biol Chem. 2006 Oct-Nov;387(10-11):1503-11.

PMID:
17081125
11.

The crystal structure of a Cys25 -> Ala mutant of human procathepsin S elucidates enzyme-prosequence interactions.

Kaulmann G, Palm GJ, Schilling K, Hilgenfeld R, Wiederanders B.

Protein Sci. 2006 Nov;15(11):2619-29.

12.

Microplate assay for quantitative determination of cathepsin activities in viable cells using derivatives of 4-methoxy-beta-naphthylamide.

Rüttger A, Mollenhauer J, Löser R, Gütschow M, Wiederanders B.

Biotechniques. 2006 Oct;41(4):469-73.

13.
14.

Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep.

Sachse A, Wagner A, Keller M, Wagner O, Wetzel WD, Layher F, Venbrocks RA, Hortschansky P, Pietraszczyk M, Wiederanders B, Hempel HJ, Bossert J, Horn J, Schmuck K, Mollenhauer J.

Bone. 2005 Nov;37(5):699-710. Epub 2005 Sep 1.

PMID:
16139577
15.

Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells.

Fitzgerald JS, Tsareva SA, Poehlmann TG, Berod L, Meissner A, Corvinus FM, Wiederanders B, Pfitzner E, Markert UR, Friedrich K.

Int J Biochem Cell Biol. 2005 Nov;37(11):2284-96. Epub 2005 Mar 17.

PMID:
16125646
16.

Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis.

Schurigt U, Stopfel N, Hückel M, Pfirschke C, Wiederanders B, Bräuer R.

Arthritis Res Ther. 2005;7(1):R174-88. Epub 2004 Dec 10.

17.

Functions of propeptide parts in cysteine proteases.

Wiederanders B, Kaulmann G, Schilling K.

Curr Protein Pept Sci. 2003 Oct;4(5):309-26. Review.

PMID:
14529526
18.

Structure-function relationships in class CA1 cysteine peptidase propeptides.

Wiederanders B.

Acta Biochim Pol. 2003;50(3):691-713. Review.

19.

An unfolding/refolding step helps in the crystallization of a poorly soluble protein.

Kaulmann G, Palm GJ, Schilling K, Hilgenfeld R, Wiederanders B.

Acta Crystallogr D Biol Crystallogr. 2003 Jul;59(Pt 7):1243-5. Epub 2003 Jun 27.

PMID:
12832773
20.

Cytochemical demonstration of expression and distribution of non-glycosylated human lysosomal cathepsin S in HEK 293 cells.

Nissler K, Oehring H, Krieg R, Pierskalla A, Weber E, Wiederanders B, Halbhuber KJ.

Cell Mol Biol (Noisy-le-grand). 2002;48 Online Pub:OL297-308.

PMID:
12643447
21.
22.

Foldase function of the cathepsin S proregion is strictly based upon its domain structure.

Pietschmann S, Fehn M, Kaulmann G, Wenz I, Wiederanders B, Schilling K.

Biol Chem. 2002 Sep;383(9):1453-8.

PMID:
12437139
23.

Splice variants of human cathepsin L mRNA show different expression rates.

Abudula A, Rommerskirch W, Weber E, Günther D, Wiederanders B.

Biol Chem. 2001 Nov;382(11):1583-91.

PMID:
11767948
24.
25.

Simultaneous enzyme overlay membrane (EOM)-based in situ zymography and immunofluorescence technique reveals cathepsin B-like activity in a subset of tumour vessels.

Berndt A, Johannesson J, Haas M, Arkona C, Katenkamp D, Wiederanders B, Hyckel P, Kosmehl H.

Histochem Cell Biol. 2000 Jul;114(1):63-8.

PMID:
10959823
26.

The function of propeptide domains of cysteine proteinases.

Wiederanders B.

Adv Exp Med Biol. 2000;477:261-70.

PMID:
10849753
27.

An evolutionarily conserved tripartite tryptophan motif stabilizes the prodomains of cathepsin L-like cysteine proteases.

Kreusch S, Fehn M, Maubach G, Nissler K, Rommerskirch W, Schilling K, Weber E, Wenz I, Wiederanders B.

Eur J Biochem. 2000 May;267(10):2965-72.

28.

The alpha1/2 helical backbone of the prodomains defines the intrinsic inhibitory specificity in the cathepsin L-like cysteine protease subfamily.

Guo YL, Kurz U, Schultz JE, Lim CC, Wiederanders B, Schilling K.

FEBS Lett. 2000 Mar 10;469(2-3):203-7.

29.

The half-life of human procathepsin S.

Nissler K, Strubel W, Kreusch S, Rommerskirch W, Weber E, Wiederanders B.

Eur J Biochem. 1999 Aug;263(3):717-25.

30.

Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile.

Kolkhorst V, Stürzebecher J, Wiederanders B.

J Cancer Res Clin Oncol. 1998;124(11):598-606.

PMID:
9860288
31.

Sorting of non-glycosylated human procathepsin S in mammalian cells.

Nissler K, Kreusch S, Rommerskirch W, Strubel W, Weber E, Wiederanders B.

Biol Chem. 1998 Feb;379(2):219-24.

PMID:
9524075
32.

Cathepsin E immunoreactivity in human ocular tissues: influence of aging and pathological states.

Bernstein HG, Reichenbach A, Wiederanders B.

Neurosci Lett. 1998 Jan 16;240(3):135-8.

PMID:
9502222
33.

The inhibition of cathepsin S by its propeptide--specificity and mechanism of action.

Maubach G, Schilling K, Rommerskirch W, Wenz I, Schultz JE, Weber E, Wiederanders B.

Eur J Biochem. 1997 Dec 15;250(3):745-50.

34.

The genes of the lysosomal cysteine proteinases cathepsin B, H, L, and S map to different mouse chromosomes.

Deussing J, Roth W, Rommerskirch W, Wiederanders B, von Figura K, Peters C.

Mamm Genome. 1997 Apr;8(4):241-5.

PMID:
9096102
35.
36.

Sequence analysis and distribution of two new human cathepsin L splice variants.

Rescheleit DK, Rommerskirch WJ, Wiederanders B.

FEBS Lett. 1996 Oct 7;394(3):345-8.

37.

The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review.

Bernstein HG, Kirschke H, Wiederanders B, Pollak KH, Zipress A, Rinne A.

Mol Chem Neuropathol. 1996 Apr;27(3):225-47. Review.

PMID:
9147410
38.

An immunohistochemical study of cathepsin E in Alzheimer-type dementia brains.

Bernstein HG, Wiederanders B.

Brain Res. 1994 Dec 26;667(2):287-90.

PMID:
7697369
39.

Cathepsin L immunoreactivity in the hypothalamus of normal, streptozotocin-diabetic and vasopressin-deficient Brattleboro rats.

Bernstein HG, Roskoden T, Kirschke H, Hahn HJ, Wiederanders B, Novakova V.

Cell Mol Biol (Noisy-le-grand). 1994 Mar;40(2):159-64.

PMID:
8003946
40.

Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth.

Weber E, Günther D, Laube F, Wiederanders B, Kirschke H.

J Cancer Res Clin Oncol. 1994;120(9):564-7.

PMID:
8045924
41.

Cathepsin S and related lysosomal endopeptidases.

Kirschke H, Wiederanders B.

Methods Enzymol. 1994;244:500-11. No abstract available.

PMID:
7845228
42.

Synthesis of phosphorylated oligosaccharides in lysozyme is enhanced by fusion to cathepsin D.

Horst M, Mares M, Zabe M, Hummel M, Wiederanders B, Kirschke H, Hasilik A.

J Biol Chem. 1993 Sep 15;268(26):19690-6.

43.

Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme.

Brömme D, Bonneau PR, Lachance P, Wiederanders B, Kirschke H, Peters C, Thomas DY, Storer AC, Vernet T.

J Biol Chem. 1993 Mar 5;268(7):4832-8.

44.

Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines.

Heidtmann HH, Salge U, Havemann K, Kirschke H, Wiederanders B.

Oncol Res. 1993;5(10-11):441-51.

PMID:
8054705
45.

Phylogenetic conservation of cysteine proteinases. Cloning and expression of a cDNA coding for human cathepsin S.

Wiederanders B, Brömme D, Kirschke H, von Figura K, Schmidt B, Peters C.

J Biol Chem. 1992 Jul 5;267(19):13708-13.

46.

Lysosomal proteinases as putative diagnostic tools in human neuropathology: Alzheimer disease (AD) and schizophrenia.

Bernstein HG, Kirschke H, Wiederanders B, Khudoerkov RM, Hinz W, Rinne A.

Acta Histochem Suppl. 1992;42:19-24.

PMID:
1584965
47.

Primary structure of bovine cathepsin S. Comparison to cathepsins L, H, B and papain.

Wiederanders B, Broemme D, Kirschke H, Kalkkinen N, Rinne A, Paquette T, Toothman P.

FEBS Lett. 1991 Jul 29;286(1-2):189-92.

48.

Ultrastructural study of cathepsin B immunoreactivity in rat brain neurons: lysosomal and extralysosomal localizations of the antigen.

Kloss P, Bernstein HG, Kirschke H, Wiederanders B.

Acta Anat (Basel). 1991;142(2):138-40.

PMID:
1781253
49.

Localization and activity of various lysosomal proteases in Leishmania amazonensis-infected macrophages.

Prina E, Antoine JC, Wiederanders B, Kirschke H.

Infect Immun. 1990 Jun;58(6):1730-7.

50.

Antigenic expression of cathepsin B in aged human brain.

Bernstein HG, Kirschke H, Wiederanders B, Schmidt D, Rinne A.

Brain Res Bull. 1990 Apr;24(4):543-9.

PMID:
2357585

Supplemental Content

Loading ...
Support Center